ARS MEDICAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ARS MEDICAL
Largest movements
- Receivables within one year +€31,791
up €31,791 (+479%), from €6,637 to €38,428
- Tangible fixed assets +€14,830
up €14,830 (+574%), from €2,582 to €17,412
- Cash +€4,770
new in 2025: €4,770
mainly Net result for the year (+€40,290) and Tax, wage and social debts (+€11,102)
- Reserves +€40,290
up €40,290 (+797%), from €5,056 to €45,346
- Tax, wage and social debts +€11,102
up €11,102 (+514%), from €2,161 to €13,263
- Gross operating margin +€45,945
up €45,945 (+435%), from €10,551 to €56,496
- Taxes +€11,102
up €11,102 (+514%), from €2,161 to €13,263
- Depreciation +€2,471
up €2,471 (+591%), from €418 to €2,889
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €9,219 | €60,610 | +€51,391 | +557% |
| Fixed assets | 21/28 | €2,582 | €17,412 | +€14,830 | +574% |
| Tangible fixed assets | 22/27 | €2,582 | €17,412 | +€14,830 | +574% |
| Plant, machinery and equipment | 23 | €2,582 | €17,412 | +€14,830 | +574% |
| Current assets | 29/58 | €6,637 | €43,198 | +€36,561 | +551% |
| Amounts receivable within one year | 40/41 | €6,637 | €38,428 | +€31,791 | +479% |
| Other amounts receivable | 41 | €6,637 | €38,428 | +€31,791 | +479% |
| Cash at bank and in hand | 54/58 | - | €4,770 | +€4,770 | |
| Total equity and liabilities | 10/49 | €9,219 | €60,610 | +€51,391 | +557% |
| Equity | 10/15 | €7,056 | €47,346 | +€40,290 | +571% |
| Contributions | 10/11 | €2,000 | €2,000 | = | 0.0% |
| Reserves | 13 | €5,056 | €45,346 | +€40,290 | +797% |
| Distributable reserves | 133 | €5,056 | €45,346 | +€40,290 | +797% |
| Amounts payable | 17/49 | €2,163 | €13,263 | +€11,101 | +513% |
| Amounts payable within one year | 42/48 | €2,163 | €13,263 | +€11,101 | +513% |
| Financial debts | 43 | €1 | - | -€1 | |
| Credit institutions | 430/8 | €1 | - | -€1 | |
| Taxes, remuneration and social security | 45 | €2,161 | €13,263 | +€11,102 | +514% |
| Taxes | 450/3 | €2,161 | €13,263 | +€11,102 | +514% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €418 | €2,889 | +€2,471 | +591% |
| Gross operating margin | 9900 | €10,551 | €56,496 | +€45,945 | +435% |
| Operating profit (loss) | 9901 | €10,133 | €53,608 | +€43,474 | +429% |
| Financial charges | 65/66B | €75 | €54 | -€21 | -28.0% |
| Recurring financial charges | 65 | €75 | €54 | -€21 | -28.0% |
| Profit (loss) for the period before taxes | 9903 | €10,058 | €53,554 | +€43,495 | +432% |
| Income taxes | 67/77 | €2,161 | €13,263 | +€11,102 | +514% |
| Profit (loss) for the period | 9904 | €7,897 | €40,290 | +€32,394 | +410% |
| Profit (loss) for the period to be appropriated | 9905 | €7,897 | €40,290 | +€32,394 | +410% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.